Montelukast effect in acne treatment
Phase 3
- Conditions
- Acne.Acne vulgaris
- Registration Number
- IRCT2017020632402N1
- Lead Sponsor
- Vice Chancellor for research, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patients with acne; being at the age of 15-45 years old; using antibiotic and other acne treatments for less than 3 months. Exclusion criteria: age under 14 year-old and older than 45 year-old; indication for systemic retinoid treatment; nodulocystic acne (with scar formation possibility); antibiotic treatment for more than 3 months; Hormonal related acne(polycystic ovarian disease)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acne severity. Timepoint: Before treatment, 1 month and 3 months after treatment. Method of measurement: Acne global severity scale questionnaire.
- Secondary Outcome Measures
Name Time Method Drug Side effects. Timepoint: 1 month and 3 months after the begining of treatment. Method of measurement: Asking patients.